Vijaya Diagnostic Centre Limited — Updates, 12-02-2025: Press Release

Vijaya Diagnostic Centre Limited has delivered an impressive Q3 FY2025 report, showcasing a 27.3% year-on-year revenue growth to ₹1,689.8 million, fueled by increased volumes in both Pathology and Radiology segments. Operational performance reflects a total of 3.68 million tests conducted, a 27.6% increase, with total footfall rising by 19.3% to 1.05 million. The consolidated EBITDA also surged by 28.3% to ₹671.3 million, bringing the EBITDA margin to 39.7%. Profit after tax climbed 36% to ₹351.6 million, marking a notable PAT margin of 20.8%.

Strategically, the company has initiated its first centre in Pune following its acquisition of PH Diagnostic Centre, with plans to launch six additional hubs in various regions within the next three months. This expansion indicates a positive outlook, bolstered by key hires aimed at supporting growth. With substantial year-to-date growth of 29.4% in revenue and a strong operational footprint, Vijaya is well-positioned for continued success, making it an intriguing prospect for investors.